Drug
Acam2000 Smallpox Vaccine
Acam2000 Smallpox Vaccine: highest development phase Phase 2, developed by Emergent BioSolutions. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Emergent BioSolutions
Trials
| Drug | Phase | Indication |
|---|---|---|
| ACAM2000 Smallpox Vaccine NCT00053482 | Phase 2 | Smallpox |
Latest
No recent events.
Follow Acam2000 Smallpox Vaccine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.